Search Videos and More
Clinical trial tests promising CAR T-cell therapy for lupus
UCI Health has launched a groundbreaking clinical trial for a next-generation CAR T-cell therapy.UCI Health expands living donor kidney program with new surgical director
Christina Papageorge, MD joins as Surgical Director of the Living Donor Kidney program, bringing deep expertise in multiorgan and minimally invasive transplantation.Gastroenterologist spotlights complementary modalities of whole-person care
Kiran Sachdev, MD blends traditional gastroenterology with integrative medicine to offer new hope for complex gut disorders.Next-generation testing in patients with non-small cell lung cancer
Tumor sequencing at the time of progression, whether tissue or liquid biopsy, is important to identify the mechanism of resistance.UCI Health oncologist presents at 2025 ESMO Targeted Anticancer Therapies Asia Congress
Jennifer Valerin, MD, PhD shares early Phase 1 results on BA 3182, a novel bispecific T cell engager, at ESMO TAT Asia 2025.Researcher is awarded grant from BrightFocus Foundation’s National Glaucoma Research Program
UCI researcher receives BrightFocus funding to explore how eye pressure and aging impact vision loss.Four UCI Health Hospitals earn top honor
Four hospitals recognized by the American Heart Association for excellence in stroke, heart failure, and diabetes care.UCI Health grows their structural heart program
Our interventional cardiologists and heart surgeons work together to treat conditions without open-heart surgery.Getting help for thyroid eye disease
Jeremiah Tao, MD, left, and Lilangi Ediriwickrema, MD work closely with a team of specialists to treat thyroid eye disease.Deepti Pandita, MD honored with HIMSS Changemaker Award
Deepti Pandita, MD, has been honored with a Healthcare Information and Management Systems Society (HIMSS) Changemaker Award.Oncologists discuss first day of American Society of Clinical Oncology (ASCO) 2024 Annual Meeting
Obesity-uterine cancer link a ‘public health’ emergencyUCI Health launches first U.S. trial of nerve-blocking device for drug-resistant hypertension
A new clinical trial at UCI Health tests a novel device that could help millions with uncontrolled high blood pressure reduce or eliminate medications.